Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025-1

Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists’ perspectives

Karen Dahri, Kimberley Sinclair (formerly MacNeil), Jolanta Piszczek [...]

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

Retricted access

Research article

First published 2026

Development of a pharmacist-led drug interaction assessment service for patients with cancer diagnosed with mild to moderate COVID-19 infection requiring outpatient treatment

Khushminder Dhillon, Sonia Szombathy, Mandeep Bains [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2024-12

Supratherapeutic INR During Treatment With Nirmatrelvir/Ritonavir and Warfarin and Acute Illness With COVID-19: A Case Report

Caitlin Dowd-Green, Dannielle Brown, Alexandra Wilson [...]

Journal of Pharmacy Practice

Free access

Research article

First published 2022-8

Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic,Paxlovid™

Jean G. Sathish, Siddhartha Bhatt, Jamie K. DaSilva [...]

International Journal of Toxicology

Open access

Research article

First published 2026

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database

Xiaomo Xiong, Zhanghe Chen, Bingfang Yan

Therapeutic Advances in Drug Safety

Retricted access

Case report

First published 2025-1

Acquired Aquagenic Syringeal Keratoderma Following COVID-19 Infection

Bryce W. Polascik, Samantha P. Karklins, Matthew C. Johnson [...]

HAND

Open access

Research article

First published 2026

Effectiveness of Nirmatrelvir/Ritonavir in Unvaccinated COVID-19 Patients Treated in the Emergency Department: A Retrospective Propensity-Matched Cohort Analysis

Dietrich von Kuenssberg Jehle, Raheed Sunesra, Shania M Williams [...]

Therapeutic Advances in Pulmonary and Critical Care Medicine

Search results

Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists’ perspectives

Development of a pharmacist-led drug interaction assessment service for patients with cancer diagnosed with mild to moderate COVID-19 infection requiring outpatient treatment

Supratherapeutic INR During Treatment With Nirmatrelvir/Ritonavir and Warfarin and Acute Illness With COVID-19: A Case Report

Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic,Paxlovid™

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database

Acquired Aquagenic Syringeal Keratoderma Following COVID-19 Infection

Effectiveness of Nirmatrelvir/Ritonavir in Unvaccinated COVID-19 Patients Treated in the Emergency Department: A Retrospective Propensity-Matched Cohort Analysis